Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight
18. November 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight According to...
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care
25. April 2024 08:30 ET
|
Mangoceuticals, Inc.
Provides MangoRx with entrance into the non-Rx based, nutraceutical product space for sales on both direct-to-consumer online platforms and through retail locations Dallas, Texas, April 25, 2024...
Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections
18. April 2024 16:10 ET
|
Barinthus Biotherapeutics
Barinthus Biotherapeutics plc (NASDAQ: BRNS), formerly Vaccitech plc, today announced topline final data from the APOLLO trial (also known as HPV001).
Sexually Transmitted Disease Testing Market revenue to exceed USD 145 Billion by 2033, says Research Nester
31. Juli 2023 07:00 ET
|
Research Nester
New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global sexually transmitted disease testing market size is predicted to grow at a CAGR of over ~6% from 2023 to 2035. The market is projected to...
Global Recombinant Vaccines Market Is Expected to Reach $24.7 Billion by 2031: Says AMR
21. Oktober 2022 11:30 ET
|
Allied Market Research
Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Recombinant Vaccines Market generated $8.1 billion in 2021 and is estimated to...
Global Human Papillomavirus Associated Cancer Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight
17. August 2022 13:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Global Human Papillomavirus Associated Cancer Pipeline Insight | Clinical Trials Research Report 2022 by DelveInsight Human Papillomavirus...
CORRECTION -- OmniPathology Announces the Launch of its Oropharyngeal HPV PCR Test
12. Juli 2022 14:55 ET
|
OmniPathology
PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by OmniPathology, please note that the second sentence in paragraph one should read "The...
OmniPathology Announces the Launch of its Oropharyngeal HPV PCR Test
12. Juli 2022 08:45 ET
|
OmniPathology
PASADENA, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus...
Global Adult Vaccines Market to Surpass US$ 29,025.87 Million by 2030, Says Coherent Market Insights (CMI)
12. Juli 2022 08:40 ET
|
CMI
Seattle, July 12, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global adult vaccines market is estimated to be valued at US$ 16,790.11 million in 2022 and is expected to...
HPV Vaccine Market: 5.73B by 2028, Human Papillomavirus Vaccine Market Growing at 5% CAGR Lead by 9-Valent HPV Vaccine Segment, Global Analysis by The Insight Partners
17. Juni 2022 08:26 ET
|
The Insight Partners
New York, June 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Human Papillomavirus (HPV) Vaccine Market Size, Share, Growth, Revenue, Trends, Forecast to 2028...